FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

KATZ LESLYE G 		2. Issuer Name and Ticker or Trading Symbol

IMS HEALTH INC [ RX ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
SVP & Chief Financial Officer
(Last)          (First)          (Middle)

C/O IMS HEALTH, 901 MAIN AVENUE, SUITE 612 		3. Date of Earliest Transaction (MM/DD/YYYY)

2/26/2010
(Street)

NORWALK, CT 06851
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   2/26/2010     A    39748   A   (1) 96292   D  
 
Common Stock   2/26/2010     D    96292   D   (2) 0   D  
 
Common Stock                  0   I   By 401 (K) Plan  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)   $16.05   2/26/2010     D         30000      (3) 5/20/2010   Common Stock   30000     (4) 0   D  
 
Stock Appreciation Right   $13.43   2/26/2010     D         68681      (5) 4/21/2016   Common Stock   68681     (6) 0   D  
 

Explanation of Responses:
( 1)  Grant of Restricted Stock Units for no cash consideration in a transaction exempt under Rule 16b-3.
( 2)  Disposition pursuant to a merger for cash consideration equal to $22.00 per share. This transaction is exempt under Rule 16b-3(e).
( 3)  Such Option became exercisable in three equal installments beginning on 5/20/2004.
( 4)  Option canceled pursuant to a merger in exchange for cash consideration equal to the difference between $22.00 and the exercise price of the Option multiplied by the number of Options canceled. This transaction is exempt under Rule 16b-3(e).
( 5)  Such Stock Appreciation Right will become exercisable in three equal installments beginning on 4/21/2010.
( 6)  Stock Appreciation Rights canceled pursuant to a merger in exchange for Stock Appreciation Rights in Healthcare Technology Holdings, Inc. The replacement award has an intrinsic value equal to that of the canceled award which is $588,596 based on the merger consideration of $22.00 per share. This transaction is exempt under Rule 16b-3(e).

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
KATZ LESLYE G
C/O IMS HEALTH
901 MAIN AVENUE, SUITE 612
NORWALK, CT 06851

SVP & Chief Financial Officer

Signatures
Alandra C. Murphy Attorney-in-Fact 3/2/2010
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
IMS Health (NYSE:RX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more IMS Health Charts.
IMS Health (NYSE:RX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more IMS Health Charts.